{"abstract": "The combination did not protect against heart attacks and strokes in a large clinical trial, and the company said it would no longer pursue its approval in the United States.", "web_url": "https://www.nytimes.com/2012/12/21/business/merck-says-niacin-combination-drug-failed-in-trial.html", "snippet": "The combination did not protect against heart attacks and strokes in a large clinical trial, and the company said it would no longer pursue its approval in the United States.", "lead_paragraph": "The drug maker Merck announced on Thursday that a combination of niacin and another medicine failed to protect against heart attacks and strokes in a large clinical trial, and that the company would no longer pursue approval of the combination drug in the United States.", "print_section": "B", "print_page": "1", "source": "The New York Times", "multimedia": [], "headline": {"main": "Merck Says Niacin Drug Has Failed Large Trial", "kicker": null, "content_kicker": null, "print_headline": "Merck Says Niacin Drug Has Failed Large Trial", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Heart", "rank": 1, "major": "N"}, {"name": "organizations", "value": "Merck & Company Inc", "rank": 2, "major": "N"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 3, "major": "N"}, {"name": "subject", "value": "Niacin", "rank": 4, "major": "N"}, {"name": "subject", "value": "Clinical Trials", "rank": 5, "major": "N"}, {"name": "subject", "value": "Stroke", "rank": 6, "major": "N"}], "pub_date": "2012-12-20T17:41:36+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Katie Thomas", "person": [{"firstname": "Katie", "middlename": null, "lastname": "Thomas", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/358c6cab-e3f3-5b8b-a0e8-da622edef8c4", "word_count": 695, "uri": "nyt://article/358c6cab-e3f3-5b8b-a0e8-da622edef8c4"}